IT1153295B - Composizione anidra stabile all'ossidazione e base di antralina o suoi derivati e suo uso nel trattamento delle malattie della pelle - Google Patents

Composizione anidra stabile all'ossidazione e base di antralina o suoi derivati e suo uso nel trattamento delle malattie della pelle

Info

Publication number
IT1153295B
IT1153295B IT23893/82A IT2389382A IT1153295B IT 1153295 B IT1153295 B IT 1153295B IT 23893/82 A IT23893/82 A IT 23893/82A IT 2389382 A IT2389382 A IT 2389382A IT 1153295 B IT1153295 B IT 1153295B
Authority
IT
Italy
Prior art keywords
anthraline
oxidation
derivatives
treatment
skin diseases
Prior art date
Application number
IT23893/82A
Other languages
English (en)
Other versions
IT8223893A0 (it
Inventor
Jean Francois Grollier
Georges Rosenbaum
Josiane Allec
Braham Shrcot
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8119952A external-priority patent/FR2515036B1/fr
Priority claimed from FR8205864A external-priority patent/FR2524313B2/fr
Application filed by Oreal filed Critical Oreal
Publication of IT8223893A0 publication Critical patent/IT8223893A0/it
Application granted granted Critical
Publication of IT1153295B publication Critical patent/IT1153295B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
IT23893/82A 1981-10-23 1982-10-22 Composizione anidra stabile all'ossidazione e base di antralina o suoi derivati e suo uso nel trattamento delle malattie della pelle IT1153295B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8119952A FR2515036B1 (fr) 1981-10-23 1981-10-23 Composition stable a l'oxydation d'anthraline ou de l'un de ses derives et son utilisation dans le traitement des maladies de la peau
FR8205864A FR2524313B2 (fr) 1982-04-05 1982-04-05 Composition stable a l'oxydation sous forme d'une dispersion ou d'une suspension d'anthraline ou de l'un de ses derives dans un alkyl-ester d'acide gras et son utilisation dans le traitement des maladies de la peau, des ongles et du cuir chevelu

Publications (2)

Publication Number Publication Date
IT8223893A0 IT8223893A0 (it) 1982-10-22
IT1153295B true IT1153295B (it) 1987-01-14

Family

ID=26222595

Family Applications (3)

Application Number Title Priority Date Filing Date
IT23892/82A IT1153294B (it) 1981-10-23 1982-10-22 Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle
IT23893/82A IT1153295B (it) 1981-10-23 1982-10-22 Composizione anidra stabile all'ossidazione e base di antralina o suoi derivati e suo uso nel trattamento delle malattie della pelle
IT23894/82A IT1153296B (it) 1981-10-23 1982-10-22 Composizione sotto forma di shampoo a base di antralina e suo uso nel trattamento delle malattie della pelle

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IT23892/82A IT1153294B (it) 1981-10-23 1982-10-22 Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle

Family Applications After (1)

Application Number Title Priority Date Filing Date
IT23894/82A IT1153296B (it) 1981-10-23 1982-10-22 Composizione sotto forma di shampoo a base di antralina e suo uso nel trattamento delle malattie della pelle

Country Status (7)

Country Link
US (3) US4513011A (it)
AU (3) AU551859B2 (it)
CA (3) CA1174171A (it)
CH (3) CH655004A5 (it)
DE (3) DE3239184C2 (it)
GB (3) GB2107587B (it)
IT (3) IT1153294B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520233A1 (fr) * 1982-01-28 1983-07-29 Oreal Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau
NZ208338A (en) * 1983-06-09 1987-11-27 Bristol Myers Co Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant
FR2570602B1 (fr) * 1984-09-21 1986-11-28 Cird Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre
US4788061A (en) * 1985-07-05 1988-11-29 Shore Ronald N Extended occlusive treatment of skin disorders
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
US5019395A (en) * 1988-03-08 1991-05-28 Warner-Lambert Company Compositions with enhanced penetration
LU87201A1 (fr) * 1988-04-14 1989-11-14 Cird Complexes a base d'anthraline et d'un sterol,leur procede d'obtention et leur utilisation en therapeutique et cosmetique
HU205860B (en) * 1990-08-24 1992-07-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositiojns for topical treating psoriasis
FR2681247B1 (fr) * 1991-09-17 1993-12-03 Oreal Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US5248494A (en) * 1992-06-10 1993-09-28 Young Pharmaceuticals Inc. Method of reducing anthralin induced inflammation and staining
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
US5776920A (en) * 1995-08-02 1998-07-07 Quarles; Ruth Method for treatment of psoriasis
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US5886038A (en) * 1998-03-24 1999-03-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
DE19926671A1 (de) * 1999-06-11 2000-12-14 Wella Ag Wasserfreie gelförmige Zusammensetzung
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US6403123B1 (en) * 2000-09-19 2002-06-11 Eugene J. Van Scott Method for topical treatment of anthralin-responsive dermatological disorders
US20030228374A1 (en) * 2002-06-07 2003-12-11 Pesacreta Thomas C. Topical treatment for skin irritation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3881000A (en) * 1971-09-08 1975-04-29 Mundipharma Ag Bis-(phosphorylated anthralin) compounds in the treatment of psoriasis and arthritis
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
GB1504007A (en) * 1976-06-28 1978-03-15 Dermal Lab Ltd Compositions containing dithranol
GB1574090A (en) * 1977-07-06 1980-09-03 Drythanol Ltd Dithranol composition for the treatment of psoriasis
DD139793A1 (de) * 1978-11-06 1980-01-23 Waltraud Braun Mittel gegen psoriasis
US4316902A (en) * 1979-09-21 1982-02-23 Yu Ruey J Therapeutic compositions and vehicles for topical pharmaceuticals
US4287214A (en) * 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
FR2492373A1 (fr) * 1980-10-21 1982-04-23 Cird Adducts de dihydroxy-1,8 anthrone-9 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US4367224A (en) * 1981-05-13 1983-01-04 Scott Eugene J Van Stable dithranol compositions in anhydrous vehicles

Also Published As

Publication number Publication date
CA1174171A (fr) 1984-09-11
GB2107588B (en) 1985-04-11
DE3239184A1 (de) 1983-05-26
AU551900B2 (en) 1986-05-15
AU551859B2 (en) 1986-05-15
CH655004A5 (fr) 1986-03-27
CH657047A5 (fr) 1986-08-15
GB2107589B (en) 1985-04-11
GB2107589A (en) 1983-05-05
US4495203A (en) 1985-01-22
AU8973482A (en) 1983-04-28
GB2107587B (en) 1985-04-11
AU551719B2 (en) 1986-05-08
DE3239181C2 (it) 1990-12-20
DE3239183A1 (de) 1983-05-05
AU8973682A (en) 1983-04-28
CH655245A5 (fr) 1986-04-15
CA1179271A (fr) 1984-12-11
CA1179270A (fr) 1984-12-11
GB2107587A (en) 1983-05-05
IT1153296B (it) 1987-01-14
GB2107588A (en) 1983-05-05
US4513011A (en) 1985-04-23
IT8223893A0 (it) 1982-10-22
IT8223892A0 (it) 1982-10-22
IT1153294B (it) 1987-01-14
US4892888A (en) 1990-01-09
AU8973582A (en) 1983-04-28
IT8223894A0 (it) 1982-10-22
DE3239181A1 (de) 1983-05-05
DE3239183C2 (it) 1990-12-13
DE3239184C2 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
IT1153295B (it) Composizione anidra stabile all'ossidazione e base di antralina o suoi derivati e suo uso nel trattamento delle malattie della pelle
IT1218836B (it) Composizione cosmetica contenente derivati idrossilati di calcone e suo impiego per la protezione della pelle e dei capelli contro le radiazioni di luce derivati di calcone e procedimento per la loro preparazione
IT1193627B (it) Composizione di antralina oppure di uno dei suoi derivati in un estere aromatico e suo impiego nel trattamento di matlattie della pelle e delle unghie
KR880002882A (ko) 티타노센 및 그의 용도
IT8768027A0 (it) Derivati di 1 piperazinil pirimidina loro preparazione e impiego in terapia e cosmesi
IT1099663B (it) Schiume fenoliche e tensioattivo utile nella preparazione delle stesse
IT1111618B (it) Derivati della canfora e loro impiego nel campo cosmetico
IT8148925A0 (it) Formulazione farmaceutica per uso locale adatta al trattamento di in fezioni della pelle e delle mucose
IT1107976B (it) Strumento e procedimento per la erogazione di fluidi in particolare per uso medicale
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
IT1182209B (it) Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
IT1272234B (it) Derivati glutationici delle antracicline e procedimento per ottenerli.
IT1231521B (it) Impiego in terapeutica di analoghi o di derivati della somatostatina
IT8149655A0 (it) Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene
FI941345A0 (fi) Retinoidit ja niiden käyttö ihosairauksien ja leukemian hoitoon
IT1106299B (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonch' composizioni farmaceutiche che la contengono
IT8249067A0 (it) L'impiego in terapeutica dei derivati della diidropiridina
IT1206796B (it) 6-trifluorometil-1h-benzotriazol-1ile-difenilfosfato e il suo impiego per preparare derivati della cefaloscporina.
IT1188704B (it) Derivati insaturi cicloalifatici,loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica
IT8819079A0 (it) Composizione conciante e sua utilizzazione nei procedimenti di concia e riconcia delle pelli animali.
IT1191110B (it) Derivati tetrazolici sostituiti in posizione 5,loro procedimento di preparazione e loro applicazione in terapia
IT8847913A0 (it) Uso di enalapril nel trattamento terapeutico delle cefalee essenziali
IT8820483A0 (it) Impiego della carnitina e derivati per la preparazione di composizioni atte al trattamento della cellulite.
ITTO920683A0 (it) Impiego di frammenti o/e di derivati della timosina alfa1
IT1230492B (it) Derivati imidazolinici di diidronaftalene e tetraidronaftalene.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971027